Clinical Trials
2 trialsNCT00840853 2025-07-09
MULTIPRAT
Baylor College of Medicine
Phase 1 Active not recruiting
NCT03448393 2025-06-04
CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory CD19/CD22-expressing B Cell Malignancies
National Institutes of Health Clinical Center (CC)
Phase 1 Completed